株式会社EXORPHIA
EXORPHIA Co., Ltd. Alias
2018-04-01
Japan
EV応用製品の研究・開発・製造・販売
EV創薬技術の導出・ライセンス供与
体外受精(IVF)用高機能添加剤の研究・開発・製造・販売
ペット用EV製剤の共同開発
Exosome-based drug delivery platform development
Exosome production and purification technology
Therapeutic development using exosome platform
〒100-0004 東京都千代田区大手町一丁目6番1号 大手町ビル6階 Inspired.Lab
口石 幸治
100,000,000 JPY
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
EDiX Professional Group
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
共立製薬
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
太田昭和監査法人
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
東京大学医科学研究所
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
松本宗大法律事務所
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
江戸川公認会計士事務所
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
順天堂大学
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Shareholder
KII
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Shareholder
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Bank
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Shareholder

18 entries
DateDescription
2019-05 会社設立
2019-05 2019年5月にEXORPHIAを設立し、代表取締役社長に就任(現任)
2019-07 第三者割当増資実施
2019-08 ラボ開設
2020-01 社内研究倫理審査委員会設立
2020-05 東京大学医科学研究所及び順天堂大学との連携開始
2021-04 本店およびラボを東京都千代田区大手町一丁目6番1号 大手町ビル6階 Inspired.Lab に移転
2021-04 第三者割当増資実施
2021-06 取締役会および監査役の設置
2022-04 第三者割当増資実施
2023-07 新株予約権によりKII及びCoral Capitalを含むVC3社から3.25億円の資金調達を実施
2023-12 共立製薬、共立ホールディングスとペット用EV製剤の共同開発契約を締結
2024-02 EXP01のPre-IND申請に関して米FDAからポジティブ回答を受領
2024-03 新株予約権によりロート製薬と共立製薬から5.5億円の資金調達を実施
2024-04 東京医科歯科大学(現・東京科学大学)と腎不全治療薬開発に関する共同研究を開始
2024-12 NEDO「ディープテック・スタートアップ支援事業」に採択
2024-12 Coral Capitalから1.8億円の追加投資
2025-04 三重大学と体外受精における卵子成熟技術に関する共同研究を開始
+ Loaded when opened
7010001200707
Trade name株式会社EXORPHIA
Trade name (kana)エクソーフィア
Name in English
Corporation type301
Address〒100-0004 東京都千代田区大手町1丁目6番1号大手町ビル6階Inspired.Lab
Postal code1000004
Prefecture code13
City code101
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date2019-05-14
Update date2021-05-06
Change date2021-04-15
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record1
Excluded from search0
Processing type12
Correction type0
Trade name image ID
Address image ID
Sequence number2173472
Source: National Tax Agency Corporate Number Publication Site, basic three items
7010001200707
Corporate number7010001200707
Trade name株式会社EXORPHIA
Trade name (kana)エクソーフィア
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address東京都千代田区大手町1丁目6番1号大手町ビル6階Inspired.Lab
Postal code1000004
Prefecture東京都
Prefecture code13
City or district千代田区
City code101
Street address大手町1丁目6番1号大手町ビル6階Inspired.Lab
Organisation type301
Processing type12
Correction type0
Status
Representative
Capital
Employees
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date2021-05-06
Key information7010001200707
Source: gBizINFO (Ministry of Economy, Trade and Industry)
2026-09-21 18:14 (Model: ggml-org/gpt-oss-20b )
↑